OSCCX
Price
$23.40
Change
+$0.18 (+0.78%)
Updated
Aug 21 closing price
Net Assets
2.63B
VRTIX
Price
$464.16
Change
+$3.94 (+0.86%)
Updated
Aug 21 closing price
Net Assets
17.5B
Interact to see
Advertisement

OSCCX vs VRTIX

OSCCX vs VRTIX Comparison Chart in %
View a ticker or compare two or three
VS
OSCCX vs. VRTIX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OSCCX is a Hold and VRTIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VRTIX has more cash in the bank: 17.5B vs. OSCCX (2.63B). VRTIX pays higher dividends than OSCCX: VRTIX (1.12) vs OSCCX (0.30). OSCCX was incepted earlier than VRTIX: OSCCX (13 years) vs VRTIX (16 years). OSCCX (1.80) is less costly to investors than VRTIX (0.05). OSCCX is a more actively managed with annual turnover of: 53.00 vs. VRTIX (14.00). OSCCX has a lower initial minimum investment than VRTIX: OSCCX (1000) vs VRTIX (5000000). VRTIX annual gain was more profitable for investors over the last year : 33.16 vs. OSCCX (13.86). VRTIX return over 5 years is better than : 41.82 vs. OSCCX (19.17).
OSCCXVRTIXOSCCX / VRTIX
Total Expense Ratio1.800.053,600%
Annual Report Gross Expense Ratio1.800.053,600%
Fund Existence13 years16 years-
Gain YTD18.60122.07984%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.63B17.5B15%
Annual Yield % from dividends0.301.1227%
Returns for 1 year13.8633.1642%
Returns for 3 years34.6365.0253%
Returns for 5 years19.1741.8246%
Returns for 10 years86.32152.0857%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XBI165.732.35
+1.44%
State Street® SPDR® S&P® Biotech ETF
HQL22.380.30
+1.36%
abrdn Life Sciences Investors
FMED32.530.42
+1.30%
Fidelity Disruptive Medicine ETF
IDVZ34.910.28
+0.80%
Polen International Div Inc ETF
RHTX20.30N/A
N/A
RH Tactical Outlook ETF